Arcadia Biosciences, Inc. (RKDA) Financials

$4.46

$0.01 (0.23%)
Last update: 04:00 PM EST
Day's range
$4.33
Day's range
$4.56
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning201820182019201920202020202120212022202220232023202420240%0%-1000%-1000%-2000%-2000%-3000%-3000%-4000%-4000%Profit Margin
Profit Margin
Revenue
Earnings

RKDA Income statement / Annual

Last year (2024), Arcadia Biosciences, Inc.'s total revenue was $5.05 M, a decrease of 5.35% from the previous year. In 2024, Arcadia Biosciences, Inc.'s net income was -$7.04 M. See Arcadia Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $5.05 M $5.33 M $9.96 M $6.78 M $8.03 M $1.17 M $1.46 M $4.03 M $3.19 M $5.41 M
Cost of Revenue $2.96 M $3.30 M $9.80 M $8.71 M $5.20 M $885.00 K $661.00 K $283.00 K $895.00 K $892.00 K
Gross Profit $2.08 M $2.03 M $154.00 K -$1.93 M $2.84 M $284.00 K $803.00 K $3.74 M $2.29 M $4.52 M
Gross Profit Ratio 0.41 0.38 0.02 -0.28 0.35 0.24 0.55 0.93 0.72 0.84
Research and Development Expenses $53.00 K $1.39 M $1.51 M $3.89 M $7.96 M $7.10 M $6.07 M $7.41 M $8.66 M $8.97 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $16.47 M $13.57 M $11.60 M $10.65 M $12.25 M $11.12 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $9.64 M $14.51 M $18.05 M $22.94 M $16.47 M $13.57 M $11.60 M $10.65 M $12.25 M $11.12 M
Other Expenses -$3.96 M $0.00 $33.00 K $0.00 $105.00 K $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $5.73 M $15.90 M $19.56 M $26.83 M $24.43 M $20.67 M $17.67 M $18.06 M $20.91 M $20.09 M
Cost And Expenses $12.66 M $19.20 M $29.36 M $35.54 M $29.63 M $21.55 M $18.33 M $18.34 M $21.81 M $20.98 M
Interest Income $782.00 K $695.00 K $289.00 K $0.00 $0.00 $5.00 K $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $20.00 K $47.00 K $5.00 K $0.00 $747.00 K $1.32 M $2.66 M
Depreciation & Amortization $0.00 $287.00 K $1.36 M $1.05 M $662.00 K $194.00 K $154.00 K $279.00 K $304.00 K $294.00 K
EBITDA -$7.50 M -$13.58 M -$13.65 M -$23.27 M -$5.44 M -$28.67 M -$13.32 M -$14.66 M -$17.98 M -$14.98 M
EBITDA Ratio -1.49 -2.55 -1.37 -3.43 -0.68 -24.53 -9.1 -3.64 -5.64 -2.77
Operating Income Ratio -0.72 -2.6 -1.95 -5.24 -2.69 -17.43 -11.52 -3.56 -5.84 -2.87
Total Other Income/Expenses Net -$661.00 K $708.00 K $3.19 M $19.39 M $6.63 M -$9.49 M $3.40 M -$1.37 M -$979.00 K -$2.37 M
Income Before Tax -$4.31 M -$13.16 M -$15.60 M -$16.13 M -$6.15 M -$28.87 M -$13.47 M -$15.68 M -$19.60 M -$17.93 M
Income Before Tax Ratio -0.85 -2.47 -1.57 -2.38 -0.77 -24.7 -9.2 -3.89 -6.15 -3.31
Income Tax Expense $8.00 K $8.00 K $14.00 K $2.00 K -$124.00 K $2.00 K $10.00 K $26.00 K $25.00 K $26.00 K
Net Income -$7.04 M -$13.98 M -$15.61 M -$16.13 M -$6.03 M -$28.87 M -$13.48 M -$15.71 M -$19.62 M -$17.96 M
Net Income Ratio -1.4 -2.62 -1.57 -2.38 -0.75 -24.7 -9.21 -3.9 -6.16 -3.32
EPS -5.16 -11.3 -26.05 -30.33 -24.2 -181.5 -143.16 -291.38 -353.85 -503
EPS Diluted -5.16 -11.3 -26.05 -30.33 -24.2 -181.5 -143.16 -291.38 -353.85 -503
Weighted Average Shares Out $1.36 M $1.24 M $599.39 K $532.02 K $248.98 K $159.08 K $94.16 K $53.91 K $55.46 K $35.70 K
Weighted Average Shares Out Diluted $1.36 M $1.24 M $599.39 K $532.02 K $248.98 K $159.08 K $94.16 K $53.91 K $55.46 K $35.70 K
Link